Patient-Centric Approach to the Management of Spasticity

Slides:



Advertisements
Similar presentations
Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
Advertisements

{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
T HE R OLE OF PM&R IN P ROVIDING Q UALITY H EALTHCARE U N D E R S T A N D I N G Physical Medicine and Rehabilitation (PM&R) Oakwood.
How will you grade the spasticity of the patient?.
What is a Physiatrist?. Physiatry: Definition Physiatry: From Greek physikos (physical) and iatreia (art of healing) Known as Physical & Rehabilitation.
Spinal Cord Injury The average age of our patients with traumatic spinal cord injuries in 2013 was 46 years. The average age of our.
0No increase in muscle tone 1Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end range of motion when.
[Name of Presenter] [Details of patient e.g. initials, hospital number etc.] [Date of meeting]
1.05 Effective Healthcare Teams
NEUROLOGY SURVEY PRELIMINARY FINDINGS. Diagnosed Conditions of Participants.
This condition is characterized by poor coordination if speech muscles
1.05 Effective Healthcare Teams
Nat. Rev. Neurol. doi:10/1038/nrneurol
Applying the New Multiple Sclerosis Guidelines to Clinical Practice
Hospitalizations and Healthcare Costs Need for Reduction in Hospitalizations of Patients With HF
Making Decisions With Your Osteoarthritis Patients
Advances in Managing Inhibitors in Patients With Hemophilia A
Objective Assessment of RA: Expanding the Horizons
Spasticity Treatment Options
To Titrate or Not: Optimizing Treatment With Antiepileptic Drugs
New Challenges Facing Multiple Sclerosis Nurses
The Nurse View: Updates in the Management of Metastatic Colorectal Cancer.
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
The Nurse View: Best Practices in Multiple Myeloma
When Would You Use Single Inhaler Triple Therapy in COPD?
Talking to Patients About Diabetes Management
Tuberous Sclerosis Complex Fundamental Concepts in Diagnosis and Management.
Team-Based Perspectives on Successful Approaches in Treating Obesity
Multidisciplinary Perspectives on Interstitial Lung Diseases
Contemporary Issues in Psoriasis Care: A Call to Action
Should I Stay or Should I Go?
Discussion and Concluding Remarks
ADVANCED PARKINSON'S DISEASE:
Introduction. Exploring Strategies for Recognition and Management of Lower Limb Spasticity in Children.
What's New on Interventions for Lower Limb Spasticity?
Managing Polycythemia Vera in the Community Setting
Live From MDS New Developments in Parkinson's Disease Psychosis
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Program Goals Overview Is NEDA a Reasonable Target?
Systemic Lupus Erythematosus
Scientific Update.
Clinical Pearls on Hot Topics in MS
New Approaches to Insomnia Management: Impact on Clinical Practice
The Burden of Psoriasis:
Breaking News in Pemphigus Vulgaris and the Latest Updates for Your Practice.
Nat. Rev. Urol. doi: /nrurol
Are We Making Progress in the Management of Huntington Disease?
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
1.05 Effective Healthcare Teams
Communicating With Your Patients About Major Depressive Disorder
Improving Effective Basal Insulin Use in Clinical Practice
Improving Adherence to Antiplatelet Therapy After an ACS Event
Program Goal. Program Goal Disclaimer Overview.
Educational Objectives
Program Goals Overview Is NEDA a Reasonable Target?
Oral Therapies in MS.
New Lipid-Lowering Therapies
Repeated Treatments With Botulinum Toxin Type A Produce Sustained Decreases in the Limitations Associated With Focal Upper-Limb Poststroke Spasticity.
1.05 Effective Healthcare Teams
PCSK9 Inhibitors and Statin Intolerance
Championing Evidence-Based Care in Patients With Acute Low Back Pain
MS, Age, and Immune Function
1.05 Effective Healthcare Teams
Merging the Art and Science of Managing nOH in Clinical Practice
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
What's New in PAH?.
1.05 Effective Healthcare Teams
Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.
Motor Fluctuations in PD
Presentation transcript:

Patient-Centric Approach to the Management of Spasticity

Program Goals

Case 1: Post-Stroke Spasticity

Assessing the Impact of Spasticity

The Role of the Caregiver

Patient-Clinician Communication

The Effects of Stretching

Pharmacologic Treatment Options

Neurotoxins

Coordinating Spasticity Management

Case 2: Multiple Sclerosis

Discussing Spasticity in MS

Discussing Adverse Events

Patient-Clinician Communication

Quality of Life Measurements

Discussing Quality of Life

Case 3: Traumatic Brain Injury

Comorbidities and Spasticity

Botulinum Toxin Administration

Antibody Formation

Effect of Nonpharmacological Therapy

Abbreviations

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.